Astria Therapeutics Inc(ATXS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ATXS Astria Therapeutics Inc

已收盘 01-12 16:00:00 EST

12.72

-0.16

-1.24%

盘后12.63

-0.09-0.71%

16:10 EST

最高12.92	最低12.64	成交量77.92万
今开12.92	昨收12.88	日振幅2.17%
总市值7.26亿	流通市值4.88亿	总股本5,708万
成交额991.74万	换手率2.03%	流通股本3,838万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ATXS","market":"US","secType":"STK","nameCN":"Astria Therapeutics Inc","latestPrice":12.72,"timestamp":1768251600000,"preClose":12.88,"halted":0,"volume":779195,"hourTrading":{"tag":"盘后","latestPrice":12.63,"preClose":12.72,"latestTime":"16:10 EST","volume":3726,"amount":47349.72,"timestamp":1768252204053},"delay":0,"floatShares":38383000,"shares":57084838,"eps":-2.138122,"marketStatus":"已收盘","change":-0.16,"latestTime":"01-12 16:00:00 EST","open":12.92,"high":12.92,"low":12.64,"amount":9917355.915927,"amplitude":0.021739,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.138122,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1768294800000},"marketStatusCode":5,"adr":0,"listingDate":1435204800000,"exchange":"NASDAQ","adjPreClose":12.88,"preHourTrading":{"tag":"盘前","latestPrice":12.89,"preClose":12.88,"latestTime":"09:29 EST","volume":2399,"amount":31120.031915,"timestamp":1768228192063},"postHourTrading":{"tag":"盘后","latestPrice":12.63,"preClose":12.72,"latestTime":"16:10 EST","volume":3726,"amount":47349.72,"timestamp":1768252204053},"volumeRatio":1.048809,"impliedVol":0.3538,"impliedVolPercentile":0.1793},"requestUrl":"/m/hq/s/ATXS","defaultTab":"news","newsList":[{"id":"1192123739","title":"Astria Therapeutics - 投诉指控Astria及董事会涉嫌过失、过失虚假陈述及隐瞒 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1192123739","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192123739?lang=zh_cn&edition=full","pubTime":"2025-12-24 06:29","pubTimestamp":1766528949,"startTime":"0","endTime":"0","summary":"Astria Therapeutics - 投诉指控Astria及董事会涉嫌过失、过失虚假陈述及隐瞒 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATXS"],"gpt_icon":0},{"id":"1149605156","title":"Astria Therapeutics公布Alpha-Star 1B/2期Navenibart临床试验中所有注册Hae患者的最终积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1149605156","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149605156?lang=zh_cn&edition=full","pubTime":"2025-11-06 21:02","pubTimestamp":1762434123,"startTime":"0","endTime":"0","summary":"Astria Therapeutics公布Alpha-Star 1B/2期Navenibart临床试验中所有注册Hae患者的最终积极结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATXS","BK4139"],"gpt_icon":0},{"id":"1159910814","title":"Astria Therapeutics Inc：预计交易对价现金部分将通过现有资金及Blackstone融资安排提供支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1159910814","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159910814?lang=zh_cn&edition=full","pubTime":"2025-10-14 19:02","pubTimestamp":1760439748,"startTime":"0","endTime":"0","summary":"Astria Therapeutics Inc：预计交易对价现金部分将通过现有资金及Blackstone融资安排提供支持","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATXS","BK4547","BK4139","BCRX"],"gpt_icon":0},{"id":"1158897845","title":"Astria Therapeutics启动Navenibart治疗遗传性血管性水肿患者的3期Orbit-Expanse长期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1158897845","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158897845?lang=zh_cn&edition=full","pubTime":"2025-10-08 20:01","pubTimestamp":1759924905,"startTime":"0","endTime":"0","summary":"Astria Therapeutics启动Navenibart治疗遗传性血管性水肿患者的3期Orbit-Expanse长期试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATXS"],"gpt_icon":0},{"id":"1111945084","title":"Astria Therapeutics Inc现已在欧盟招募HAE患者参与三期Alpha-Orbit临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1111945084","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111945084?lang=zh_cn&edition=full","pubTime":"2025-10-02 20:01","pubTimestamp":1759406478,"startTime":"0","endTime":"0","summary":"Astria Therapeutics Inc宣布，目前正在欧盟地区招募遗传性血管性水肿(HAE)患者，以参与其关键性的三期Alpha-Orbit临床试验。\n该试验标志着公司在HAE治疗药物开发方面迈出的重要一步，将为欧盟地区的HAE患者提供参与前沿治疗研究的机会。三期临床试验是药物开发过程中的关键阶段，旨在进一步验证治疗方案的安全性和有效性。\n通过在欧盟启动患者招募工作，Astria Therapeutics Inc进一步扩大了其Alpha-Orbit试验的覆盖范围，为更多HAE患者带来了参与这项重要临床研究的可能性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATXS","BK4139"],"gpt_icon":0},{"id":"1121220257","title":"Astria Therapeutics在欧洲皮肤病学和性传播疾病学会上公布Star-0310药物1a期健康受试者试验的积极初步结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1121220257","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121220257?lang=zh_cn&edition=full","pubTime":"2025-09-17 20:01","pubTimestamp":1758110478,"startTime":"0","endTime":"0","summary":"Astria Therapeutics公司宣布，在欧洲皮肤病学和性传播疾病学会上公布了其Star-0310药物1a期健康受试者试验的积极初步结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATXS","BK4139"],"gpt_icon":0},{"id":"1112588273","title":"Astria Therapeutics将在2025年欧洲皮肤病与性病学院大会上展示Star-0310的1a期试验初步数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1112588273","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112588273?lang=zh_cn&edition=full","pubTime":"2025-09-03 20:02","pubTimestamp":1756900953,"startTime":"0","endTime":"0","summary":"Astria Therapeutics将在即将举行的2025年欧洲皮肤病与性病学院大会上公布其药物Star-0310的1a期临床试验初步数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATXS"],"gpt_icon":0},{"id":"1174790879","title":"Astria Therapeutics第四季度每股亏损$(0.44)，好于预期$(0.45)","url":"https://stock-news.laohu8.com/highlight/detail?id=1174790879","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174790879?lang=zh_cn&edition=full","pubTime":"2025-03-11 20:52","pubTimestamp":1741697555,"startTime":"0","endTime":"0","summary":"Astria Therapeutics  报告称，其季度每股亏损$，好于分析师预期的$，超出预期2.22%。该数据较去年同期的每股亏损$增加了48.84%。以上内容来自Benzinga Earnings专栏，原文如下：Astria $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 2.22 percent. This is a 48.84 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATXS","LENZ"],"gpt_icon":0},{"id":"2518209913","title":"Astria Therapeutics, Inc.盘中异动 下午盘快速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518209913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518209913?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:32","pubTimestamp":1741631578,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时32分，Astria Therapeutics, Inc.股票出现异动，股价急速下挫5.01%。Astria Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。其相关个股中，Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6045.54%、3847.86%、1007.25%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、59.34%。Astria Therapeutics, Inc.公司简介：Astria Therapeutics Inc是一家生物制药公司，致力于为受罕见和小众过敏和免疫疾病影响的患者和家庭带来改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503110232589640710a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503110232589640710a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATXS","LENZ","BK4139"],"gpt_icon":0},{"id":"2517165557","title":"Astria Therapeutics, Inc.盘中异动 股价大涨5.09%报6.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517165557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517165557?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:30","pubTimestamp":1741271449,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时30分，Astria Therapeutics, Inc.股票出现波动，股价急速拉升5.09%。Astria Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Plus Therapeutics, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Exicure, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为904.77%、95.93%、44.61%，振幅较大的相关个股有Mbx Biosciences, Inc.、Tiziana Life Sciences Ltd、Neuphoria Therapeutics Inc.，振幅分别为8.18%、8.09%、5.97%。Astria Therapeutics, Inc.公司简介：Astria Therapeutics Inc是一家生物制药公司，致力于为受罕见和小众过敏和免疫疾病影响的患者和家庭带来改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223049a2628f38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223049a2628f38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ATXS","BK4139"],"gpt_icon":0},{"id":"2516065711","title":"Astria Therapeutics, Inc.盘中异动 下午盘快速下挫5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516065711","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516065711?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:52","pubTimestamp":1741027945,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时52分，Astria Therapeutics, Inc.股票出现异动，股价快速跳水5.12%。Astria Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4444.50%、200.45%、179.81%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Astria Therapeutics, Inc.公司简介：Astria Therapeutics Inc是一家生物制药公司，致力于为受罕见和小众过敏和免疫疾病影响的患者和家庭带来改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304025226a25d8923&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304025226a25d8923&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ATXS","BK4139"],"gpt_icon":0},{"id":"2514449333","title":"HC Wainwright & Co.：重申Astria Therapeutics(ATXS.US)评级，由买入调整至买入评级, 目标价由16.00美元调整至16.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514449333","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514449333?lang=zh_cn&edition=full","pubTime":"2025-02-28 01:30","pubTimestamp":1740677455,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Astria Therapeutics(ATXS.US)评级，由买入调整至买入评级, 目标价由16.00美元调整至16.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28013048441763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","ATXS"],"gpt_icon":0},{"id":"2510335736","title":"Astria Therapeutics, Inc.盘中异动 股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510335736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510335736?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:06","pubTimestamp":1739286386,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时06分，Astria Therapeutics, Inc.股票出现异动，股价大幅跳水5.14%。Astria Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.38%。其相关个股中，Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、Dominari Holdings Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2498.79%、727.44%、325.44%，振幅较大的相关个股有Dominari Holdings Inc.、In8Bio, Inc.、Ocean Biomedical, Inc.，振幅分别为49.03%、37.99%、37.16%。Astria Therapeutics, Inc.公司简介：Astria Therapeutics Inc是一家生物制药公司，致力于为受罕见和小众过敏和免疫疾病影响的患者和家庭带来改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211230626a242028f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211230626a242028f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ATXS"],"gpt_icon":0},{"id":"2503675601","title":"Astria Therapeutics, Inc.盘中异动 股价大涨5.02%报7.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503675601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503675601?lang=zh_cn&edition=full","pubTime":"2025-01-16 02:47","pubTimestamp":1736966851,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日02时47分，Astria Therapeutics, Inc.股票出现波动，股价急速上涨5.02%。Astria Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.11%。Astria Therapeutics, Inc.公司简介：Astria Therapeutics Inc是一家生物制药公司，致力于为受罕见和小众过敏和免疫疾病影响的患者和家庭带来改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116024731abac2b97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116024731abac2b97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ATXS"],"gpt_icon":0},{"id":"2502796898","title":"Astria Therapeutics, Inc.盘中异动 股价大跌5.87%报7.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502796898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502796898?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:11","pubTimestamp":1736521919,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时11分，Astria Therapeutics, Inc.股票出现波动，股价快速下挫5.87%。Astria Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.36%。其相关个股中，Conduit Pharmaceuticals Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Precision Biosciences, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为1101.73%、400.39%、199.71%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.、Zyversa Therapeutics, Inc.，振幅分别为85.00%、41.78%、37.29%。Astria Therapeutics, Inc.公司简介：Astria Therapeutics Inc是一家生物制药公司，致力于为受罕见和小众过敏和免疫疾病影响的患者和家庭带来改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102311599861f303&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102311599861f303&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ATXS"],"gpt_icon":0},{"id":"2501775393","title":"Astria Therapeutics, Inc.盘中异动 早盘急速下跌5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501775393","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501775393?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:52","pubTimestamp":1736347978,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时52分，Astria Therapeutics, Inc.股票出现波动，股价大幅跳水5.54%。Astria Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Sana Biotechnology, Inc.、Silo Pharma, Inc.、Vir Biotechnology, Inc.涨幅较大，Silo Pharma, Inc.、60 Degrees Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为1901.08%、546.93%、519.34%，振幅较大的相关个股有Silo Pharma, Inc.、Sana Biotechnology, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为135.78%、109.09%、68.53%。Astria Therapeutics, Inc.公司简介：Astria Therapeutics Inc是一家生物制药公司，致力于为受罕见和小众过敏和免疫疾病影响的患者和家庭带来改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108225258985f7cf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108225258985f7cf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ATXS"],"gpt_icon":0},{"id":"2501626062","title":"Astria Therapeutics, Inc.盘中异动 股价大跌5.18%报8.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501626062","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501626062?lang=zh_cn&edition=full","pubTime":"2025-01-07 04:50","pubTimestamp":1736196609,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日04时50分，Astria Therapeutics, Inc.股票出现异动，股价急速下跌5.18%。Astria Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Astria Therapeutics, Inc.公司简介：Astria Therapeutics Inc是一家生物制药公司，致力于为受罕见和小众过敏和免疫疾病影响的患者和家庭带来改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107045009aba0d778&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107045009aba0d778&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATXS","LENZ","BK4139"],"gpt_icon":0},{"id":"2490114864","title":"Astria Therapeutics, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490114864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490114864?lang=zh_cn&edition=full","pubTime":"2024-12-11 23:46","pubTimestamp":1733932004,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日23时46分，Astria Therapeutics, Inc.股票出现波动，股价大幅拉升5.02%。Astria Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Astria Therapeutics, Inc.公司简介：Astria Therapeutics Inc是一家生物制药公司，致力于为受罕见和小众过敏和免疫疾病影响的患者和家庭带来改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211234644a1e6915f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211234644a1e6915f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATXS","BK4139","LENZ"],"gpt_icon":0},{"id":"2489255303","title":"Astria Therapeutics, Inc.盘中异动 股价大涨5.13%报10.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489255303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489255303?lang=zh_cn&edition=full","pubTime":"2024-12-07 00:53","pubTimestamp":1733503985,"startTime":"0","endTime":"0","summary":"北京时间2024年12月07日00时53分，Astria Therapeutics, Inc.股票出现波动，股价快速拉升5.13%。截至发稿，该股报10.25美元/股，成交量4.4452万股，换手率0.08%，振幅5.23%。Astria Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Astria Therapeutics, Inc.公司简介：Astria Therapeutics Inc是一家生物制药公司，致力于为受罕见和小众过敏和免疫疾病影响的患者和家庭带来改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207005305971c2ae1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207005305971c2ae1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ATXS","BK4139"],"gpt_icon":0},{"id":"2488672941","title":"Astria Therapeutics, Inc.盘中异动 早盘急速拉升5.05%报10.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488672941","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488672941?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:42","pubTimestamp":1733150540,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时42分，Astria Therapeutics, Inc.股票出现异动，股价快速上涨5.05%。截至发稿，该股报10.92美元/股，成交量6885股，换手率0.01%，振幅3.08%。Astria Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Astria Therapeutics, Inc.公司简介：Astria Therapeutics Inc是一家生物制药公司，致力于为受罕见和小众过敏和免疫疾病影响的患者和家庭带来改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202224221a2669efc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202224221a2669efc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ATXS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.astriatx.com","stockEarnings":[{"period":"1week","weight":-0.0008},{"period":"1month","weight":-0.0069},{"period":"3month","weight":0.5499},{"period":"6month","weight":1.022},{"period":"1year","weight":0.5425},{"period":"ytd","weight":-0.016}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0095},{"period":"3month","weight":0.0629},{"period":"6month","weight":0.113},{"period":"1year","weight":0.1774},{"period":"ytd","weight":0.0178}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Astria Therapeutics, Inc.于2008年6月26日在特拉华州成立，总部设在马萨诸塞州剑桥市。 该公司是一家生物制药公司，专注于新疗法的发现、开发和商业化。该公司的使命是通过改变生活的疗法，为那些受到罕见和小众过敏性和免疫性疾病影响的患者和家庭带来希望。该公司的主要候选产品是STAR-0215，这是一种潜在的同类最佳的血浆激肽释放酶单克隆抗体抑制剂，正在临床开发中，用于治疗遗传性血管性水肿或HAE，这是一种罕见的、使人衰弱并可能危及生命的疾病。根据迄今产生的数据和现有的HAE治疗情况，STAR-0215有可能成为对患者最友好的HAE慢性治疗方案。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":0.150939},{"month":2,"riseRate":0.3,"avgChangeRate":-0.139898},{"month":3,"riseRate":0.6,"avgChangeRate":0.098772},{"month":4,"riseRate":0.1,"avgChangeRate":-0.073586},{"month":5,"riseRate":0.4,"avgChangeRate":-0.014296},{"month":6,"riseRate":0.5,"avgChangeRate":-0.094312},{"month":7,"riseRate":0.545455,"avgChangeRate":0.023082},{"month":8,"riseRate":0.636364,"avgChangeRate":0.126193},{"month":9,"riseRate":0.454545,"avgChangeRate":0.026138},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.124679},{"month":11,"riseRate":0.545455,"avgChangeRate":0.019449},{"month":12,"riseRate":0.545455,"avgChangeRate":0.066085}],"exchange":"NASDAQ","name":"Astria Therapeutics Inc","nameEN":"Astria Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Astria Therapeutics Inc(ATXS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Astria Therapeutics Inc(ATXS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Astria Therapeutics Inc,ATXS,Astria Therapeutics Inc股票,Astria Therapeutics Inc股票老虎,Astria Therapeutics Inc股票老虎国际,Astria Therapeutics Inc行情,Astria Therapeutics Inc股票行情,Astria Therapeutics Inc股价,Astria Therapeutics Inc股市,Astria Therapeutics Inc股票价格,Astria Therapeutics Inc股票交易,Astria Therapeutics Inc股票购买,Astria Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Astria Therapeutics Inc(ATXS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Astria Therapeutics Inc(ATXS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}